ITT vs REGN · P/E 26, rev $3.63B vs P/E 14, rev $14.34B
ITT Inc (ITT) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
ITT Inc (ITT) is a specialty industrial machinery company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ITT revenue for 2024-12-31 was $3.63B. Net income was $521.7M. Revenue was up 10.6% from 2023-12-31 to 2024-12-31. ITT currently screens at market cap $12.68B and trailing P/E 25.7.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ITT currently screens at market cap $12.68B and trailing P/E 25.7. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ITT and REGN stock pages for the full models.
Not investment advice.